MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 118 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 1.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $138,000 | -89.8% | 111,194 | -74.7% | 0.00% | -100.0% |
| Q1 2017 | $1,353,000 | +15.4% | 439,585 | +53.1% | 0.00% | 0.0% |
| Q4 2016 | $1,172,000 | -51.5% | 287,202 | -24.5% | 0.00% | -50.0% |
| Q3 2016 | $2,415,000 | +92.4% | 380,334 | +63.3% | 0.00% | +100.0% |
| Q2 2016 | $1,255,000 | +30.7% | 232,928 | +103.0% | 0.00% | 0.0% |
| Q1 2016 | $960,000 | -82.0% | 114,748 | -81.6% | 0.00% | -80.0% |
| Q3 2015 | $5,319,000 | +861.8% | 625,003 | +1175.4% | 0.01% | +400.0% |
| Q4 2014 | $553,000 | -60.5% | 49,003 | -69.2% | 0.00% | 0.0% |
| Q3 2014 | $1,399,000 | +1765.3% | 159,302 | +1445.1% | 0.00% | – |
| Q2 2014 | $75,000 | +141.9% | 10,310 | +79.8% | 0.00% | – |
| Q4 2013 | $31,000 | +342.9% | 5,735 | +230.2% | 0.00% | – |
| Q3 2013 | $7,000 | – | 1,737 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
| Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
| Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
| INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
| GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
| Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
| Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |